{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:32:24Z","timestamp":1789021944529,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"publisher","award":["IISR-2020-200005"],"award-info":[{"award-number":["IISR-2020-200005"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymgme.2025.109022","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:36:12Z","timestamp":1737160572000},"page":"109022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploratory metabolomic profiling of plasma and urine in patients with mucopolysaccharidosis type II (Hunter syndrome): A pilot study"],"prefix":"10.1016","volume":"144","author":[{"given":"Asma","family":"Farjallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Maranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Auray-Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109022_bb0005","series-title":"Neurochemical Mechanisms in Disease","first-page":"785","article-title":"Lysosomal storage diseases","author":"Pastores","year":"2011"},{"key":"10.1016\/j.ymgme.2025.109022_bb0010","series-title":"Lysosomal Storage Disorders","first-page":"59","article-title":"Genetics of lysosomal storage diseases","author":"Fuller","year":"2022"},{"key":"10.1016\/j.ymgme.2025.109022_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10545-010-9079-5","article-title":"Clinical aspects of neuropathic lysosomal storage disorders","volume":"33","author":"Jardim","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13353-022-00703-1","article-title":"Misdiagnosis in mucopolysaccharidoses","volume":"63","author":"Wi\u015bniewska","year":"2022","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.ymgme.2025.109022_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-024-03195-w","article-title":"Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses","volume":"19","author":"Li","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics9040195","article-title":"Neonatal mass urine screening approach for early detection of mucopolysaccharidoses by UPLC-MS\/MS","volume":"9","author":"Menkovic","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.ymgme.2025.109022_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041258","article-title":"Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment","volume":"21","author":"D\u2019avanzo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109022_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0050","series-title":"Adv Carbohydr Chem Biochem","first-page":"71","article-title":"Chapter two - Mucopolysaccharidosis type II (Hunter syndrome): clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment","author":"Mohamed","year":"2020"},{"key":"10.1016\/j.ymgme.2025.109022_bb0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10545-017-0075-x","article-title":"Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)","volume":"40","author":"Burton","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0060","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2025.109022_bb0065","series-title":"Groundbreaking Gene Therapy Trial for Hunter Syndrome Opens","author":"Bigger","year":"2023"},{"key":"10.1016\/j.ymgme.2025.109022_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094854","article-title":"Current and future treatment of mucopolysaccharidosis (MPS) type II: is brain-targeted stem cell gene therapy the solution for this devastating disorder?","volume":"23","author":"Horgan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109022_bb0075","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography - tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2025.109022_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Auray-Blais","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109022_bb0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cca.2012.01.012","article-title":"An improved method for glycosaminoglycan analysis by LC-MS\/MS of urine samples collected on filter paper","volume":"413","author":"Auray-Blais","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109022_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.aca.2016.06.054","article-title":"UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses","volume":"936","author":"Auray-Blais","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109022_bb0095","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2025.109022_bb0100","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1021\/ac401542k","article-title":"A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients","volume":"85","author":"Manwaring","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2025.109022_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13361-014-1060-3","article-title":"Metabolomic discovery of novel urinary galabiosylceramideanalogs as Fabry disease biomarkers","volume":"26","author":"Boutin","year":"2015","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ymgme.2025.109022_bb0110","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/acs.jproteome.2c00068","article-title":"Metabolomic study using time-of-flight mass spectrometry reveals novel urinary biomarkers for gaucher disease type 1","volume":"21","author":"Menkovic","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymgme.2025.109022_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21217869","article-title":"Identification of a reliable biomarker profile for the diagnosis of gaucher disease type 1 patients using a mass spectrometry-based metabolomic approach","volume":"21","author":"Menkovic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109022_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-017-0127-2","article-title":"Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease","volume":"41","author":"Alharbi","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109022_bb0125","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2025.109022_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nprot.2011.319","article-title":"Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst","volume":"6","author":"Xia","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymgme.2025.109022_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bjo.2010.179937","article-title":"Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis","volume":"95","author":"Ferrari","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2025.109022_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091467","article-title":"Ophthalmological findings in mucopolysaccharidoses","volume":"8","author":"Tomatsu","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2025.109022_bb0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1134\/S1607672920050129","article-title":"Cognitive enhancer Noopept activates transcription factor HIF-1","volume":"494","author":"Zainullina","year":"2020","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2025.109022_bb0150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13105-023-00981-1","article-title":"Gut microbial metabolites of dietary polyphenols and their potential role in human health and diseases","volume":"79","author":"Gade","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ymgme.2025.109022_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020446","article-title":"Analysis of mucopolysaccharidosis type VI through integrative functional metabolomics","volume":"20","author":"Tebani","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109022_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2017.09.024","article-title":"Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling","volume":"475","author":"Tebani","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109022_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911724","article-title":"Pathogenic roles of heparan sulfate and its use as a biomarker in mucopolysaccharidoses","volume":"23","author":"Minami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109022_bb0170","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109022_bb0175","series-title":"X IAPO Manual of Pediatric Otorhinolaryngology","first-page":"219","article-title":"ENT manifestations of mucopolysaccharoidoses","author":"Chow","year":"2012"},{"key":"10.1016\/j.ymgme.2025.109022_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10545-012-9509-7","article-title":"Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases","volume":"36","author":"Lamari","year":"2013","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:45:14Z","timestamp":1762364714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1096719225000137"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109022","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory metabolomic profiling of plasma and urine in patients with mucopolysaccharidosis type II (Hunter syndrome): A pilot study","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109022"}}